MPM BioImpact, a leading biotech investor, is going all in on its strategy to take China-born drugs to the global stage.

Over the past year, its portfolio company K2 Therapeutics has amassed three drug programs …

Subscribe for Updates

Copyright 2025 dijee Intelligence Ltd.   dijee Intelligence Ltd. is a private limited company registered in England and Wales at Media House, Sopers Road, Cuffley, Hertfordshire, EN6 4RY, UK registration number 16808844